Net Cash Provided by (Used in) Operating Activities |
95M |
USD |
-25.2% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-146M |
USD |
-198% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-68M |
USD |
+2.86% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
1.25B |
shares |
0% |
Q2 2025 |
FY 2027 |
Common Stock, Shares, Issued |
207M |
shares |
-1.17% |
Q2 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2027 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-119M |
USD |
-1422% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
893M |
USD |
-34.3% |
Q2 2025 |
FY 2027 |
Deferred Tax Assets, Valuation Allowance |
423M |
USD |
-1.63% |
Q2 2025 |
FY 2027 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.17 |
pure |
0% |
Q2 2025 |
FY 2027 |
Deferred Tax Assets, Gross |
1.54B |
USD |
+1.12% |
Q2 2025 |
FY 2027 |
Operating Lease, Liability |
378M |
USD |
-5.26% |
Q2 2025 |
FY 2027 |
Payments to Acquire Property, Plant, and Equipment |
68M |
USD |
-2.86% |
Q3 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.46B |
USD |
+523% |
Q2 2025 |
FY 2027 |
Lessee, Operating Lease, Liability, to be Paid |
516M |
USD |
-8.51% |
Q2 2025 |
FY 2027 |
Property, Plant and Equipment, Gross |
10.3B |
USD |
+0.68% |
Q2 2025 |
FY 2027 |
Operating Lease, Liability, Current |
61M |
USD |
0% |
Q2 2025 |
FY 2027 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
64M |
USD |
+1.59% |
Q2 2025 |
FY 2027 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.09 |
pure |
0% |
Q2 2025 |
FY 2027 |
Deferred Income Tax Expense (Benefit) |
-3M |
USD |
-111% |
Q3 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
138M |
USD |
-16.4% |
Q2 2025 |
FY 2027 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
FY 2027 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
FY 2027 |
Unrecognized Tax Benefits |
107M |
USD |
-4.46% |
Q2 2025 |
FY 2027 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
FY 2027 |
Depreciation, Depletion and Amortization |
64M |
USD |
-15.8% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
1.12B |
USD |
+2.2% |
Q2 2025 |
FY 2027 |
Interest Expense |
333M |
USD |
0% |
Q4 2024 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2027 |